Bridging gaps in AI-driven cardio-oncology: global advances and Middle East perspectives.

ABSTRACT:

Background

Cardiotoxicity remains a critical barrier to effective cancer treatment, contributing significantly to morbidity and mortality in cancer survivors. Recent advancements (2020-2025) highlight artificial intelligence (AI) as a transformative tool in cardio-oncology, enhancing cardiotoxicity detection, personalized risk assessment, and patient management. Despite rapid technological progress, significant gaps remain in AI integration across different healthcare settings globally.

Methods

This narrative review systematically synthesizes literature published between 2020 and 2025, evaluating key applications of AI in cardio-oncology, including imaging modalities, predictive modeling, wearable technology, and clinical decision-support systems. Comparative analyses betwee

SUBMITTER: Albulushi A 

PROVIDER: S-EPMC12659457 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature